Skip to main content

Security report for biotechmedgraz.at

BioTechMed-Graz · Education · Austria

Medium risk. 6 critical or high findings in GDPR outside view, Email security and 2 other checks.

Security score

68/100

Risk levelMedium

0–100, higher is better. How it is calculated

BioTechMed-Graz is a collaborative research initiative uniting Universität Graz, Technische Universität Graz, and Medizinische Universität Graz to foster cutting-edge research, cooperation, and networking in Graz. The platform focuses on supporting young scientists, promoting excellent research projects, and jointly acquiring research infrastructure. The website reflects a professional academic presence with clear communication and accessible contact information. Technically, the site is built on TYPO3 CMS with Angular components, leveraging Matomo and Google Analytics for user insights while respecting privacy and consent. Security posture is solid with HTTPS, cookie consent, and no visible vulnerabilities, though explicit security policies and incident response details are absent. Overall, the domain registration aligns with the academic nature and location, supporting legitimacy and trustworthiness.

Scanned

NIS2 and GDPR posture

GDPR outside view
43/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1

Need hands-on remediation? Email guard@offseq.com

Keep watching biotechmedgraz.at

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
80
Email security
40
DNS health
75
Network security
100
GDPR outside view
43
Average
68

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The organization occupies a niche academic research cooperation market, leveraging partnerships with major universities in Graz. Its business model centers on collaborative research funding and infrastructure sharing rather than commercial sales. The target audience includes researchers, students, and academic institutions. The presence of partner logos and linked domains indicates a strong partnership ecosystem. The website content and structure support a medium-sized entity with a focus on education and healthcare sectors. Growth indicators include active event promotion and young researcher support programs.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, cookie consent mechanisms, and use of privacy-respecting analytics. No critical vulnerabilities or exposed sensitive data were detected. However, the absence of published security policies, incident response contacts, and vulnerability disclosure mechanisms suggests room for improvement in transparency and readiness. The site follows GDPR compliance with a comprehensive privacy policy and cookie consent. Security headers appear to be implemented but could be explicitly confirmed and enhanced with CSP.

Recommendations

  1. Publish a dedicated security policy and incident response plan on the website.
  2. Implement and publicize a vulnerability disclosure policy (security.txt) to encourage responsible reporting.
  3. Add contact information for a Data Protection Officer or security contact email.
  4. Regularly review and update third-party scripts and analytics tools to mitigate vulnerabilities.
  5. Enhance HTTP security headers, especially Content-Security-Policy, to reduce attack surface.

Contact details published on the site

Addresses
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
BioTechMed-Graz
Description
BioTechMed-Graz ist eine Forschungskooperation der Universität Graz, der Technischen Universität Graz und der Medizinischen Universität Graz. Sie stärkt Spitzenforschung, Kooperation und Vernetzung am Forschungsstandort Graz. Zu den wichtigsten Zielen zählen die Unterstützung des wissenschaftlichen Nachwuchses, die Förderung exzellenter Forschungsprojekte sowie die gemeinsame Anschaffung von Forschungsinfrastruktur.
Key services
Forschungsförderung, Kooperation und Vernetzung, Unterstützung des wissenschaftlichen Nachwuchses, Gemeinsame Anschaffung von Forschungsinfrastruktur
Content quality
good
Branding
consistent

Technology

Stack
TYPO3 CMS, Angular, Matomo Analytics, Google Analytics, Bootstrap (implied by classes), JavaScript ES6 modules
Frameworks
TYPO3 CMS, Angular
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML
  • Use of Matomo with consent
  • No visible vulnerable libraries

Analytics and tracking

Services
Matomo, Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a professional academic cooperation platform for research institutions in Graz.
  2. Content is primarily in German with English alternate available.
  3. No signs of malicious or suspicious activity.
  4. Good privacy and cookie compliance with consent mechanisms.
  5. No explicit terms of service found.
  6. Contact information is clearly provided including email, phone, and physical address.
  7. Use of modern CMS TYPO3 and Angular framework.
  8. Analytics usage respects user consent.
  9. No advertising or affiliate marketing detected.
Technical notes

Notes

The website uses TYPO3 CMS combined with Angular for frontend components, indicating a modern and modular architecture. Hosting appears to be managed by Universität Graz, ensuring institutional reliability. Performance is moderate with compressed CSS and JS assets, asynchronous script loading, and responsive design. Accessibility features such as skip links and ARIA attributes are implemented, supporting inclusive access. SEO is supported by meta tags, canonical links, and language alternates. Opportunities exist to optimize loading speed further and explicitly document technical security headers.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biotechmedgraz.at. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biotechmedgraz.at.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.